The median plasma GPBB concentration in patients with high-grade glioma is almost two- to threefold greater than in non-malignant patients, with a cut-off value for the diagnosis of an acute coronary syndrome at 10 ng/ml (Lee et al., 2012). The gene discussed is PYGB; the disease is central nervous system cancer.